Cite
HARVARD Citation
Finelli, C. et al. (n.d.). Addition of Lenalidomide to Azacitidine in Higher Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study. Leukemia research. pp. S50-S51. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Finelli, C. et al. (n.d.). Addition of Lenalidomide to Azacitidine in Higher Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study. Leukemia research. pp. S50-S51. [Online].